Alliancebernstein L.P. Mersana Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 168,810 shares of MRSN stock, worth $313,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,810

Previous 118,180 42.84%

Holding current value

$313,986

Previous $274,000 175.91%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.16 - $5.94 $109,360 - $300,742	50,630 Added 42.84%	168,810 $756,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $13,941 - $29,390	-12,560 Reduced 9.61%	118,180 $274,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $91,138 - $336,181	-85,980 Reduced 39.67%	130,740 $166,000
Q2 2023 Aug 15, 2023	BUY	$3.08 - $9.55 $360,421 - $1.12 Million	117,020 Added 117.37%	216,720 $713,000
Q3 2022 Nov 15, 2022	BUY	$4.63 - $8.0 $45,374 - $78,400	9,800 Added 10.9%	99,700 $674,000

Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $35,784 - $63,000	12,600 Added 16.3%	89,900 $415,000
Q1 2022 May 13, 2022	BUY	$3.74 - $6.63 $748 - $1,326	200 Added 0.26%	77,300 $308,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $27,948 - $50,286	5,100 Added 7.08%	77,100 $480,000
Q1 2021 May 06, 2021	SELL	$15.31 - $26.52 $96,453 - $167,076	-6,300 Reduced 8.05%	72,000 $1.17 Million
Q3 2020 Nov 12, 2020	BUY	$16.2 - $25.7 $16,200 - $25,700	1,000 Added 1.29%	78,300 $1.46 Million
Q2 2020 Aug 13, 2020	BUY	$5.24 - $23.4 $200,692 - $896,220	38,300 Added 98.21%	77,300 $1.81 Million
Q1 2020 May 14, 2020	BUY	$4.41 - $9.28 $114,219 - $240,351	25,900 Added 197.71%	39,000 $227,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $50,304 - $83,840	13,100 New	13,100 $53,000
Q3 2018 Nov 08, 2018	SELL	$10.0 - $19.02 $579,000 - $1.1 Million	-57,900 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$14.2 - $22.68 $822,180 - $1.31 Million	57,900 New	57,900 $1.03 Million

Others Institutions Holding MRSN

# of Institutions

128

Shares Held

118M

Call Options Held

68.1K

Put Options Held

140K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $181M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Mersana Therapeutics, Inc. Transaction History